NFKB1 and B-cell chronic lymphocytic leukemia: In addition, the CLL-association substitutions are more likely than expected to alter the binding affinity of NFKB and PAX5 in both the gained and lost dREs, compatible with the functions of these TFs in CLL as well as normal B-cells.